Methylin ER and Methylphenidate Extended-Release Capsules (Evening Formulation)
Determining the interaction of Methylin ER and Methylphenidate Extended-Release Capsules (Evening Formulation) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Methylin ER, Ritalin SR, Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Metadate CD, Daytrana
Synonyms: n.a.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylin ER-Methylphenidate Extended-Release Chewable Tablets
- Methylin ER-Methylphenidate Extended-Release Oral Suspension
- Methylin ER-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Methylin ER-Methylphenidate Extended-Release Tablets
- Methylin ER-Methylphenidate Hydrochloride
- Methylin ER-Methylphenidate LA Capsules
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Methylin Oral Solution
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Methylnaltrexone
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Methylnaltrexone bromide
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Methylnaltrexone Injection
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Methylnaltrexone oral/injection
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Methylnaltrexone Subcutaneous